Filter Results :

Your search for Cancer Vaccine returned 22 reports

Sort by


Global Cancer Vaccines Market 2015-2019

17 Jun 2015  |  Published by:  Technavio
About Cancer VaccinesCancer vaccines are biological preparations that stimulate or strengthen a person’s immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic a...

$ 2,500.00

Read More

US Cancer Vaccine Market Outlook 2020

20 May 2015  |  Published by:  KuicK Research
"Escalating cancer incidences have made the investigators to come forth with therapeutics that could reduce high morbidity and mortality rates. Cancer segment has several products belonging to different categories having different pharmacological efficacy. So, it becomes imperative for investi...

$ 2,000.00

Read More

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

24 Feb 2015  |  Published by:  KuicK Research
Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targ...

$ 1,200.00

Read More

Global Skin Cancer Vaccine Market & Pipeline Insight 2015

24 Feb 2015  |  Published by:  KuicK Research
Skin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used fo...

$ 1,500.00

Read More

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

26 Jan 2015  |  Published by:  MarketsandMarkets
Report Description The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment ...

$ 4,650.00

Read More

Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015

14 Jan 2015  |  Published by:  PNS Pharma
Prostate cancer has emerged as a disease with one of the highest incidences and mortality rates in males across the world. This situation has created a large unmet medical demand for better therapeutics by patients suffering from prostate cancer due to modest response generated by presently av...

$ 1,500.00

Read More

Cancer Vaccines: Technologies and Global Markets

01 Jan 2015  |  Published by:  BCC Research
The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019. This report provides:-An overview of the globa...

$ 6,650.00

Read More

Dendritic Cell Cancer Vaccine Market & Clinical Insight

01 Jan 2015  |  Published by:  KuicK Research
Dendritic cells are branched cells found in lymphoid organs and they are responsible for antigen display and T-cell activation. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. In 1868, Paul Langerhans discovered dendritic cel...

$ 1,800.00

Read More

Cancer Vaccine Partnering Terms and Agreements

01 Dec 2014  |  Published by:  CurrentPartnering
 The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in cancer vaccine partnering deals -Disclosed headlines, upfronts, milestones and ...

$ 1,995.00

Read More

Global Breast Cancer Vaccine Clinical Trial Insight

29 Oct 2014  |  Published by:  KuicK Research
“Global Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: • Global Breast Cancer Vaccine Market Overview • Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country • Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines • Detailed Clinical In...

$ 1,200.00

Read More

Global Cancer Vaccines Market & Pipeline Analysis

09 Sep 2014  |  Published by:  KuicK Research
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. Therapeutic or Treatme...

$ 2,400.00

Read More

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018

01 Jul 2014  |  Published by:  MarketsandMarkets
Report Description The report segments the cell culture market into two distinct market segments, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The segments of the cell culture equipment market included in this report are bio-safety cabinet...

$ 4,650.00

Read More

US Cancer Vaccine Pipeline Analysis

01 Jan 2014  |  Published by:  PNS Pharma
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, ma...

$ 1,500.00

Read More

Global Cancer Vaccines Pipeline Analysis

25 Sep 2013  |  Published by:  PNS Pharma
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic canc...

$ 1,800.00

Read More

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

31 Mar 2013  |  Published by:  GBI Research
Summary“Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake”. There is currently only one marketed therapeutic cancer vaccine, Provenge, which is indicated for the treatment of castrate¬–resi...

$ 3,500.00

Read More
Total 22 records.